167 related articles for article (PubMed ID: 26752139)
1. Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010.
Baronciani D; Angelucci E; Potschger U; Gaziev J; Yesilipek A; Zecca M; Orofino MG; Giardini C; Al-Ahmari A; Marktel S; de la Fuente J; Ghavamzadeh A; Hussein AA; Targhetta C; Pilo F; Locatelli F; Dini G; Bader P; Peters C
Bone Marrow Transplant; 2016 Apr; 51(4):536-41. PubMed ID: 26752139
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.
Caocci G; Orofino MG; Vacca A; Piroddi A; Piras E; Addari MC; Caria R; Pilia MP; Origa R; Moi P; La Nasa G
Am J Hematol; 2017 Dec; 92(12):1303-1310. PubMed ID: 28850704
[TBL] [Abstract][Full Text] [Related]
3. Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.
Thompson AA; Walters MC; Kwiatkowski J; Rasko JEJ; Ribeil JA; Hongeng S; Magrin E; Schiller GJ; Payen E; Semeraro M; Moshous D; Lefrere F; Puy H; Bourget P; Magnani A; Caccavelli L; Diana JS; Suarez F; Monpoux F; Brousse V; Poirot C; Brouzes C; Meritet JF; Pondarré C; Beuzard Y; Chrétien S; Lefebvre T; Teachey DT; Anurathapan U; Ho PJ; von Kalle C; Kletzel M; Vichinsky E; Soni S; Veres G; Negre O; Ross RW; Davidson D; Petrusich A; Sandler L; Asmal M; Hermine O; De Montalembert M; Hacein-Bey-Abina S; Blanche S; Leboulch P; Cavazzana M
N Engl J Med; 2018 Apr; 378(16):1479-1493. PubMed ID: 29669226
[TBL] [Abstract][Full Text] [Related]
4. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
[TBL] [Abstract][Full Text] [Related]
5. A Multicenter Retrospective Analysis Stressing the Importance of Long-Term Follow-Up after Hematopoietic Cell Transplantation for β-Thalassemia.
Chaudhury S; Ayas M; Rosen C; Ma M; Viqaruddin M; Parikh S; Kharbanda S; Chiang KY; Haight A; Bhatia M; Guilcher G; Thompson A; Shenoy S
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1695-1700. PubMed ID: 28627425
[TBL] [Abstract][Full Text] [Related]
6. Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.
Shenoy S; Thompson AA
Ann N Y Acad Sci; 2016 Mar; 1368(1):122-6. PubMed ID: 26999376
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors.
Anurathapan U; Hongeng S; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Charoenkwan P; Jetsrisuparb A; Sanpakit K; Rujkijyanont P; Meekaewkunchorn A; Lektrakul Y; Iamsirirak P; Surapolchai P; Satayasai W; Sirireung S; Sruamsiri R; Wahidiyat PA; Ungkanont A; Issaragrisil S; Andersson BS
Bone Marrow Transplant; 2016 Jun; 51(6):813-8. PubMed ID: 26878659
[TBL] [Abstract][Full Text] [Related]
8. Thalassaemia.
Taher AT; Weatherall DJ; Cappellini MD
Lancet; 2018 Jan; 391(10116):155-167. PubMed ID: 28774421
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation for people with ß-thalassaemia major.
Jagannath VA; Fedorowicz Z; Al Hajeri A; Sharma A
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008708. PubMed ID: 27900772
[TBL] [Abstract][Full Text] [Related]
10. Management of iron overload before, during, and after hematopoietic stem cell transplantation for thalassemia major.
Angelucci E; Pilo F
Ann N Y Acad Sci; 2016 Mar; 1368(1):115-21. PubMed ID: 26999450
[TBL] [Abstract][Full Text] [Related]
11. Related and unrelated donor transplantation for β-thalassemia major: results of an international survey.
Li C; Mathews V; Kim S; George B; Hebert K; Jiang H; Li C; Zhu Y; Keesler DA; Boelens JJ; Dvorak CC; Agarwal R; Auletta JJ; Goyal RK; Hanna R; Kasow K; Shenoy S; Smith AR; Walters MC; Eapen M
Blood Adv; 2019 Sep; 3(17):2562-2570. PubMed ID: 31471325
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Stem Cell Transplantation in Thalassemia.
Strocchio L; Locatelli F
Hematol Oncol Clin North Am; 2018 Apr; 32(2):317-328. PubMed ID: 29458734
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies.
Magrin E; Miccio A; Cavazzana M
Blood; 2019 Oct; 134(15):1203-1213. PubMed ID: 31467062
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy of hemoglobinopathies: progress and future challenges.
Ikawa Y; Miccio A; Magrin E; Kwiatkowski JL; Rivella S; Cavazzana M
Hum Mol Genet; 2019 Oct; 28(R1):R24-R30. PubMed ID: 31322165
[TBL] [Abstract][Full Text] [Related]
15. Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia.
Xu S; Luk K; Yao Q; Shen AH; Zeng J; Wu Y; Luo HY; Brendel C; Pinello L; Chui DHK; Wolfe SA; Bauer DE
Blood; 2019 May; 133(21):2255-2262. PubMed ID: 30704988
[TBL] [Abstract][Full Text] [Related]
16. Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative.
de la Fuente J; Dhedin N; Koyama T; Bernaudin F; Kuentz M; Karnik L; Socié G; Culos KA; Brodsky RA; DeBaun MR; Kassim AA
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1197-1209. PubMed ID: 30500440
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells.
Dever DP; Bak RO; Reinisch A; Camarena J; Washington G; Nicolas CE; Pavel-Dinu M; Saxena N; Wilkens AB; Mantri S; Uchida N; Hendel A; Narla A; Majeti R; Weinberg KI; Porteus MH
Nature; 2016 Nov; 539(7629):384-389. PubMed ID: 27820943
[TBL] [Abstract][Full Text] [Related]
18. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
Eapen M; Brazauskas R; Walters MC; Bernaudin F; Bo-Subait K; Fitzhugh CD; Hankins JS; Kanter J; Meerpohl JJ; Bolaños-Meade J; Panepinto JA; Rondelli D; Shenoy S; Williamson J; Woolford TL; Gluckman E; Wagner JE; Tisdale JF
Lancet Haematol; 2019 Nov; 6(11):e585-e596. PubMed ID: 31495699
[TBL] [Abstract][Full Text] [Related]
19. Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia.
Marktel S; Scaramuzza S; Cicalese MP; Giglio F; Galimberti S; Lidonnici MR; Calbi V; Assanelli A; Bernardo ME; Rossi C; Calabria A; Milani R; Gattillo S; Benedicenti F; Spinozzi G; Aprile A; Bergami A; Casiraghi M; Consiglieri G; Masera N; D'Angelo E; Mirra N; Origa R; Tartaglione I; Perrotta S; Winter R; Coppola M; Viarengo G; Santoleri L; Graziadei G; Gabaldo M; Valsecchi MG; Montini E; Naldini L; Cappellini MD; Ciceri F; Aiuti A; Ferrari G
Nat Med; 2019 Feb; 25(2):234-241. PubMed ID: 30664781
[TBL] [Abstract][Full Text] [Related]
20. A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?
Cappellini MD; Porter JB; Viprakasit V; Taher AT
Blood Rev; 2018 Jul; 32(4):300-311. PubMed ID: 29455932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
